Changing the World in Healthcare, Education, and Energy through Science, Technology, and Social Entrepreneurship & Innovation!
“Global health and global education problems & challenges are a single-point failure for humanity.”
Tissue engineering involves using cells, biomaterials, and growth factors to repair or replace damaged tissues and organs. It combines three main components: cells from the patient or donor, biochemical signals to guide cell growth, and scaffolds that support new tissue formation. Researchers are working on techniques like autologous chondrocyte implantation to regenerate cartilage, intervertebral disc regeneration, encapsulating pancreatic islets, and developing bone and cartilage substitutes using stem cells.
Tissue engineering scaffolds are being developed for cleft palate reconstruction. The objectives are to engineer anatomically correct and functional human bone grafts for congenital defects using stem cells and biomaterial scaffolds. Ideal scaffolds would be biocompatible, biodegradable, immunologically inert, and support stem cell differentiation into bone cells. Research involves developing biomimetic scaffolds that mimic bone microstructure and using bioreactor systems to culture stem cells on scaffolds to form vascularized bone grafts for craniofacial reconstruction.
Doris Taylor Building New Hearts: Regenerative Medicine Becomes a RealityKim Solez ,
Dr. Doris Taylor presents "Building New Hearts: Regenerative Medicine Becomes a Reality" at the Banff Transplant Pathology meeting in Vancouver October 5, 2015.
Tissue engineering aims to reconstruct tissues and organs by growing new tissue from cells onto a scaffold. It provides an alternative to transplantation by producing tissues customized for patients. Recent advances include improved scaffold materials for bone tissue engineering using osteoinductive and hybrid materials. Scientists have also engineered heart and nerve tissues that closely mimic natural tissues, with the heart tissue even beating when implanted. Tissue engineering holds promise for treating currently untreatable medical conditions but further research is still needed.
A fun activity to teach the concept of tissue engineering to students and even kids! This was developed by the Binghamton BMES student chapter and also used as a case study submission for the Biomaterials class by the developers of this idea. It will showcase at the Binghamton University 2016 Engineers Week for young students in the local community.
1. Drug release scaffolds can be categorized as cell delivery scaffolds or drug delivery scaffolds, with common parameters including 3D architecture, porosity, composition, interfaces, degradability, and mimicking the ECM.
2. Specific parameters for drug release scaffolds include loading capacity, drug distribution, binding affinity, and stability.
3. Injectable hydrogel scaffolds show advantages over implantation scaffolds for drug release, including enabling sustained release upon swelling to control release behavior with minimal invasiveness.
Tissue engineering involves using cells, biomaterials, and growth factors to repair or replace damaged tissues and organs. It combines three main components: cells from the patient or donor, biochemical signals to guide cell growth, and scaffolds that support new tissue formation. Researchers are working on techniques like autologous chondrocyte implantation to regenerate cartilage, intervertebral disc regeneration, encapsulating pancreatic islets, and developing bone and cartilage substitutes using stem cells.
Tissue engineering scaffolds are being developed for cleft palate reconstruction. The objectives are to engineer anatomically correct and functional human bone grafts for congenital defects using stem cells and biomaterial scaffolds. Ideal scaffolds would be biocompatible, biodegradable, immunologically inert, and support stem cell differentiation into bone cells. Research involves developing biomimetic scaffolds that mimic bone microstructure and using bioreactor systems to culture stem cells on scaffolds to form vascularized bone grafts for craniofacial reconstruction.
Doris Taylor Building New Hearts: Regenerative Medicine Becomes a RealityKim Solez ,
Dr. Doris Taylor presents "Building New Hearts: Regenerative Medicine Becomes a Reality" at the Banff Transplant Pathology meeting in Vancouver October 5, 2015.
Tissue engineering aims to reconstruct tissues and organs by growing new tissue from cells onto a scaffold. It provides an alternative to transplantation by producing tissues customized for patients. Recent advances include improved scaffold materials for bone tissue engineering using osteoinductive and hybrid materials. Scientists have also engineered heart and nerve tissues that closely mimic natural tissues, with the heart tissue even beating when implanted. Tissue engineering holds promise for treating currently untreatable medical conditions but further research is still needed.
A fun activity to teach the concept of tissue engineering to students and even kids! This was developed by the Binghamton BMES student chapter and also used as a case study submission for the Biomaterials class by the developers of this idea. It will showcase at the Binghamton University 2016 Engineers Week for young students in the local community.
1. Drug release scaffolds can be categorized as cell delivery scaffolds or drug delivery scaffolds, with common parameters including 3D architecture, porosity, composition, interfaces, degradability, and mimicking the ECM.
2. Specific parameters for drug release scaffolds include loading capacity, drug distribution, binding affinity, and stability.
3. Injectable hydrogel scaffolds show advantages over implantation scaffolds for drug release, including enabling sustained release upon swelling to control release behavior with minimal invasiveness.
The document summarizes advancements in 3D bioprinting and electrospinning techniques for fabricating tissue scaffolds and enabling cell growth from 1998 to 2014. It describes key studies that used 3D printing and electrospinning to create scaffolds from various polymers for tissue engineering applications. The studies demonstrated improved cell adhesion, proliferation and infiltration on 3D printed and electrospun scaffolds compared to traditional fabrication methods. The techniques continued to advance through the use of additional biomaterials and the creation of hybrid and multilayered scaffold structures.
This document discusses tissue engineering and the use of scaffolds for growing cells. It describes several scaffold design techniques including nanofibre self-assembly, gas foaming, CAD/CAM technologies, and electrospinning. Scaffolds provide a structure for cells to attach, migrate, and grow into tissues. The future of this technology could enable the creation of more complex organs and possibly whole bodies. However, issues around cost and ethics will need to be addressed as the technology advances.
This document summarizes the application of nanotechnology to regenerative medicine. It begins with background on regenerative medicine and its focus on repairing damaged tissues through stem cell therapy and tissue engineering. It then discusses how nanotechnology can help because biological processes occur on the nanoscale. Examples are given of FDA-approved regenerative products showing the commercial potential. Developments in regenerative medicine using stem cells and gene therapy for various diseases are also outlined. In general, the document shows how nanotechnology may improve regenerative approaches by better interacting with cellular structures and components that function on the nanoscale level.
Kim Solez Bridge between transplantation and regenerative medicine vancouver3Kim Solez ,
Dr. Kim Solez presents "Bridge between Transplantation and Regenerative Medicine" at the Banff Transplant Pathology meeting in Vancouver October 5, 2015. Copyright (c) 2015, JustMachines Inc.
Tissue engineering/regenerative medicine involves making tissues or organs for use inside or outside the body, or using tissues for research purposes. Key areas of research include biomaterials to guide cell growth, methods for acquiring and differentiating cells, growth factors and proteins, engineering design aspects like bioreactors, and assessing properties of native and engineered tissues. Current therapies include autografts, allografts, xenografts, and man-made materials, but have issues like rejection, shortage of donors, and high costs. Topics of active research include treatments for trauma, wound healing, respiratory disease, bone/joint repair, and heart/vascular disease.
This document provides an overview of the field of tissue engineering. It defines tissue engineering as an interdisciplinary field that applies engineering and life science principles toward the development of biological substitutes that restore or improve tissue function. The key goals of tissue engineering are to repair, replace, or regenerate tissues and whole organs. Current clinical treatments involve grafting methods like autografts, allografts, and xenografts, but these have limitations like immune rejection and donor scarcity. Tissue engineering aims to address these issues by using scaffolds, cells, and growth factors to regenerate tissues. Challenges in the field include properly mimicking the tissue microenvironment, scaling up production, and developing vascularization within engineered tissues.
Tissue engineering in heart and valve failure management.drucsamal
This document summarizes research on tissue engineering approaches for treating heart and valve failure. It discusses developing cardiac patches made of biomaterials seeded with cells, testing patches in animal models, and evaluating function. Heart valve engineering using scaffolds seeded with human cells is also reviewed. Whole heart engineering by decellularizing and repopulating rat hearts is presented. Clinical perspectives are discussed, such as enrolling patients for efficacy tests of engineered myocardial tissue and assessing safety issues. The goal is developing tissue engineering therapies for treating unmet clinical needs in heart disease.
Biomaterials for tissue engineering slideshareBukar Abdullahi
An overview of Tissue Engineering with some basics in Biomaterials and Synthetic Polymers. Further references should be considered as I presented this a specific target audience.
The document discusses scaffolds for tissue engineering. It defines scaffolds as temporary or permanent artificial extracellular matrices that accommodate cells and support 3D tissue regeneration. Scaffolds aim to mimic the natural extracellular matrix and promote cell response to engineer replacement tissues. The key requirements for scaffolds are that they be porous, biocompatible, and have properties matching the target tissue. Various fabrication techniques can be used to control the scaffold architecture, composition, and other properties. Common scaffold materials discussed include natural polymers like collagen and synthetic polymers.
The document discusses research at the Liu Nanobionics Lab, which focuses on biomaterials, tissue engineering, and nanotechnology. The lab aims to address tissue damage from disease or injury by developing regenerative approaches rather than just replacement. This includes designing scaffolds, surface modifications, and cell encapsulation techniques to facilitate tissue regeneration. The goal is to shift from static tissue replacement to stimulating the body's natural healing abilities.
This document discusses bioengineering, stem cells, and bioprinting. It explains that tissue engineering applies principles of engineering and life sciences to develop biological substitutes that restore or improve organ/tissue function. The methodology involves recruiting cells, interacting them with biomaterials, and implanting seeded matrices. Normal cell structures and functions are also described, including the plasma membrane, cytoskeleton, extracellular matrix, and mechanisms of cell-ECM and cell-biomaterial interaction. Potential cell sources for tissue engineering are discussed.
Regenerative medicine is a relatively new field of study that treats
injuries and diseases by harnessing the body’s own regenerative
capabilities. Check out this video to know more about Regenerative Medicine!
Facebook @https://www.facebook.com/Orthogencare-157416978420231/
Twitter@https://twitter.com/OrthogenC
Linkedin@http://linkedin.com/company/orthogen-care
Book an appointment @https://www.orthogencare.com/book-an-appointment
Contact us @ https://www.orthogencare.com/contact-us
#Regencare #RegenerativeMedicine
#OrthogenP
This document provides an overview of tissue engineering. It discusses the process of tissue engineering which involves using a scaffold material, seeding it with living cells, using growth factors, and implanting the new tissue. It also describes different types of stem cells, materials used for scaffolds, and methods to synthesize tissue engineered scaffolds. Applications of tissue engineering include bioartificial organs and tissues like skin, bone, and blood vessels. Both advantages and disadvantages of the field are mentioned.
Tissue engineering involves growing tissues or organs by seeding cells onto biodegradable scaffolds. There are several key steps in the tissue engineering process: (1) cells are isolated from a patient and cultured, (2) the cells are seeded onto a scaffold to allow adhesion and growth, (3) the seeded scaffolds may be placed in a bioreactor to mimic the body's conditions and stimulate growth, (4) the engineered tissues are implanted into the patient. Bioreactors help distribute cells throughout the scaffold and provide mechanical and chemical cues to influence cell behavior.
Tissue engineering involves using scaffolds, cells, and biomolecules to create functional 3D tissues. It aims to develop biological substitutes to restore tissue function and repair damaged tissues, avoiding problems with organ transplants, mechanical devices, and surgery. A major goal is designing scaffolds that recreate the in vivo microenvironment through biophysical and biochemical signaling. Stem cells are a promising cell source for their ability to integrate into tissues and secrete growth factors. Signaling molecules can also be used to modulate cell behavior. Magnetic targeting of stem cells may help with the challenge of cell retention in tissue engineering applications like cardiac repair.
TISSUE DEVELOPMENT WITH TISSUE ENGINEERING APPROACHFelix Obi
Tissue Engineering is the development and practice of combining scaffolds, cells, and suitable biochemical factors (regulatory factors or Signals) into functional tissues. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs.
Cells are the building blocks of tissue, and tissues are the basic unit of function in the body. Generally, groups of cells make and secrete their own support structures, called extracellular matrix. This matrix, or scaffold, does more than just support the cells; it also acts as a relay station for various signaling molecules. Thus, cells receive messages from many sources that become available from the local environment. Each signal can start a chain of responses that determine what happens to the cell. By understanding how individual cells respond to signals, interact with their environment, and organize into tissues and organisms, Tissue Engineers are now able to manipulate these processes to amend damaged tissues or even create new ones.
Characteristics of the biomaterials for tissue engineering applicationsaumya pandey
This document discusses biomaterials used for tissue engineering applications. It defines biomaterials as any synthetic or natural substances used to replace or augment tissues and organs in the body. Common biomaterials include ceramics, polymers, and metals. Ceramics like hydroxyapatite are similar to bone but are brittle. Polymers can be natural like collagen or synthetic and are flexible but may not integrate well. Metals are strong but can corrode. The document examines the properties and applications of these materials and outlines the challenges of using each for tissue engineering.
Tissue engineering uses scaffolds, cells, and signaling molecules to regenerate tissues and organs. Scaffolds provide a structure for cell attachment, growth, and tissue formation. Natural polymers like collagen and hyaluronic acid, and synthetic polymers like poly-lactic-co-glycolic acid are commonly used as scaffold materials. Scaffolds can be fabricated using various methods including freeze drying, electrospinning, 3D printing, and textile technologies to produce scaffolds with desirable properties like porosity and pore size for tissue growth. Scaffolds seeded with stem cells or tissue-specific cells aim to repair and regenerate tissues for applications in skin, bone, cartilage, and other organs.
This is my short presentation in one of my university classes. It's obvious that the future of the stem cell biology is tightly engaged with organoids and they will absolutely change the way science is going to.
Kind regards
Shahin Ahmadian
The future interface of mental health with information technology: high touch...HealthXn
The document discusses the future of mental health and technology, including:
- Technology may help address challenges in healthcare systems but also presents pitfalls if not implemented carefully.
- The roles of health professionals and patients may change as technology becomes more integrated in care, requiring new skills.
- Data and information from various sources can provide insights if analyzed properly, but also raise privacy and security concerns.
- Future health systems will rely more on knowledge management and using data/analytics to provide personalized, predictive care while maintaining the human touch.
May 2021 snapshot of some of the Research and Collaborations in dHealth/personalized health, public health, epidemiology, biomedicine at the AI Institute of the University of South Carolina [AIISC]
The document summarizes advancements in 3D bioprinting and electrospinning techniques for fabricating tissue scaffolds and enabling cell growth from 1998 to 2014. It describes key studies that used 3D printing and electrospinning to create scaffolds from various polymers for tissue engineering applications. The studies demonstrated improved cell adhesion, proliferation and infiltration on 3D printed and electrospun scaffolds compared to traditional fabrication methods. The techniques continued to advance through the use of additional biomaterials and the creation of hybrid and multilayered scaffold structures.
This document discusses tissue engineering and the use of scaffolds for growing cells. It describes several scaffold design techniques including nanofibre self-assembly, gas foaming, CAD/CAM technologies, and electrospinning. Scaffolds provide a structure for cells to attach, migrate, and grow into tissues. The future of this technology could enable the creation of more complex organs and possibly whole bodies. However, issues around cost and ethics will need to be addressed as the technology advances.
This document summarizes the application of nanotechnology to regenerative medicine. It begins with background on regenerative medicine and its focus on repairing damaged tissues through stem cell therapy and tissue engineering. It then discusses how nanotechnology can help because biological processes occur on the nanoscale. Examples are given of FDA-approved regenerative products showing the commercial potential. Developments in regenerative medicine using stem cells and gene therapy for various diseases are also outlined. In general, the document shows how nanotechnology may improve regenerative approaches by better interacting with cellular structures and components that function on the nanoscale level.
Kim Solez Bridge between transplantation and regenerative medicine vancouver3Kim Solez ,
Dr. Kim Solez presents "Bridge between Transplantation and Regenerative Medicine" at the Banff Transplant Pathology meeting in Vancouver October 5, 2015. Copyright (c) 2015, JustMachines Inc.
Tissue engineering/regenerative medicine involves making tissues or organs for use inside or outside the body, or using tissues for research purposes. Key areas of research include biomaterials to guide cell growth, methods for acquiring and differentiating cells, growth factors and proteins, engineering design aspects like bioreactors, and assessing properties of native and engineered tissues. Current therapies include autografts, allografts, xenografts, and man-made materials, but have issues like rejection, shortage of donors, and high costs. Topics of active research include treatments for trauma, wound healing, respiratory disease, bone/joint repair, and heart/vascular disease.
This document provides an overview of the field of tissue engineering. It defines tissue engineering as an interdisciplinary field that applies engineering and life science principles toward the development of biological substitutes that restore or improve tissue function. The key goals of tissue engineering are to repair, replace, or regenerate tissues and whole organs. Current clinical treatments involve grafting methods like autografts, allografts, and xenografts, but these have limitations like immune rejection and donor scarcity. Tissue engineering aims to address these issues by using scaffolds, cells, and growth factors to regenerate tissues. Challenges in the field include properly mimicking the tissue microenvironment, scaling up production, and developing vascularization within engineered tissues.
Tissue engineering in heart and valve failure management.drucsamal
This document summarizes research on tissue engineering approaches for treating heart and valve failure. It discusses developing cardiac patches made of biomaterials seeded with cells, testing patches in animal models, and evaluating function. Heart valve engineering using scaffolds seeded with human cells is also reviewed. Whole heart engineering by decellularizing and repopulating rat hearts is presented. Clinical perspectives are discussed, such as enrolling patients for efficacy tests of engineered myocardial tissue and assessing safety issues. The goal is developing tissue engineering therapies for treating unmet clinical needs in heart disease.
Biomaterials for tissue engineering slideshareBukar Abdullahi
An overview of Tissue Engineering with some basics in Biomaterials and Synthetic Polymers. Further references should be considered as I presented this a specific target audience.
The document discusses scaffolds for tissue engineering. It defines scaffolds as temporary or permanent artificial extracellular matrices that accommodate cells and support 3D tissue regeneration. Scaffolds aim to mimic the natural extracellular matrix and promote cell response to engineer replacement tissues. The key requirements for scaffolds are that they be porous, biocompatible, and have properties matching the target tissue. Various fabrication techniques can be used to control the scaffold architecture, composition, and other properties. Common scaffold materials discussed include natural polymers like collagen and synthetic polymers.
The document discusses research at the Liu Nanobionics Lab, which focuses on biomaterials, tissue engineering, and nanotechnology. The lab aims to address tissue damage from disease or injury by developing regenerative approaches rather than just replacement. This includes designing scaffolds, surface modifications, and cell encapsulation techniques to facilitate tissue regeneration. The goal is to shift from static tissue replacement to stimulating the body's natural healing abilities.
This document discusses bioengineering, stem cells, and bioprinting. It explains that tissue engineering applies principles of engineering and life sciences to develop biological substitutes that restore or improve organ/tissue function. The methodology involves recruiting cells, interacting them with biomaterials, and implanting seeded matrices. Normal cell structures and functions are also described, including the plasma membrane, cytoskeleton, extracellular matrix, and mechanisms of cell-ECM and cell-biomaterial interaction. Potential cell sources for tissue engineering are discussed.
Regenerative medicine is a relatively new field of study that treats
injuries and diseases by harnessing the body’s own regenerative
capabilities. Check out this video to know more about Regenerative Medicine!
Facebook @https://www.facebook.com/Orthogencare-157416978420231/
Twitter@https://twitter.com/OrthogenC
Linkedin@http://linkedin.com/company/orthogen-care
Book an appointment @https://www.orthogencare.com/book-an-appointment
Contact us @ https://www.orthogencare.com/contact-us
#Regencare #RegenerativeMedicine
#OrthogenP
This document provides an overview of tissue engineering. It discusses the process of tissue engineering which involves using a scaffold material, seeding it with living cells, using growth factors, and implanting the new tissue. It also describes different types of stem cells, materials used for scaffolds, and methods to synthesize tissue engineered scaffolds. Applications of tissue engineering include bioartificial organs and tissues like skin, bone, and blood vessels. Both advantages and disadvantages of the field are mentioned.
Tissue engineering involves growing tissues or organs by seeding cells onto biodegradable scaffolds. There are several key steps in the tissue engineering process: (1) cells are isolated from a patient and cultured, (2) the cells are seeded onto a scaffold to allow adhesion and growth, (3) the seeded scaffolds may be placed in a bioreactor to mimic the body's conditions and stimulate growth, (4) the engineered tissues are implanted into the patient. Bioreactors help distribute cells throughout the scaffold and provide mechanical and chemical cues to influence cell behavior.
Tissue engineering involves using scaffolds, cells, and biomolecules to create functional 3D tissues. It aims to develop biological substitutes to restore tissue function and repair damaged tissues, avoiding problems with organ transplants, mechanical devices, and surgery. A major goal is designing scaffolds that recreate the in vivo microenvironment through biophysical and biochemical signaling. Stem cells are a promising cell source for their ability to integrate into tissues and secrete growth factors. Signaling molecules can also be used to modulate cell behavior. Magnetic targeting of stem cells may help with the challenge of cell retention in tissue engineering applications like cardiac repair.
TISSUE DEVELOPMENT WITH TISSUE ENGINEERING APPROACHFelix Obi
Tissue Engineering is the development and practice of combining scaffolds, cells, and suitable biochemical factors (regulatory factors or Signals) into functional tissues. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs.
Cells are the building blocks of tissue, and tissues are the basic unit of function in the body. Generally, groups of cells make and secrete their own support structures, called extracellular matrix. This matrix, or scaffold, does more than just support the cells; it also acts as a relay station for various signaling molecules. Thus, cells receive messages from many sources that become available from the local environment. Each signal can start a chain of responses that determine what happens to the cell. By understanding how individual cells respond to signals, interact with their environment, and organize into tissues and organisms, Tissue Engineers are now able to manipulate these processes to amend damaged tissues or even create new ones.
Characteristics of the biomaterials for tissue engineering applicationsaumya pandey
This document discusses biomaterials used for tissue engineering applications. It defines biomaterials as any synthetic or natural substances used to replace or augment tissues and organs in the body. Common biomaterials include ceramics, polymers, and metals. Ceramics like hydroxyapatite are similar to bone but are brittle. Polymers can be natural like collagen or synthetic and are flexible but may not integrate well. Metals are strong but can corrode. The document examines the properties and applications of these materials and outlines the challenges of using each for tissue engineering.
Tissue engineering uses scaffolds, cells, and signaling molecules to regenerate tissues and organs. Scaffolds provide a structure for cell attachment, growth, and tissue formation. Natural polymers like collagen and hyaluronic acid, and synthetic polymers like poly-lactic-co-glycolic acid are commonly used as scaffold materials. Scaffolds can be fabricated using various methods including freeze drying, electrospinning, 3D printing, and textile technologies to produce scaffolds with desirable properties like porosity and pore size for tissue growth. Scaffolds seeded with stem cells or tissue-specific cells aim to repair and regenerate tissues for applications in skin, bone, cartilage, and other organs.
This is my short presentation in one of my university classes. It's obvious that the future of the stem cell biology is tightly engaged with organoids and they will absolutely change the way science is going to.
Kind regards
Shahin Ahmadian
The future interface of mental health with information technology: high touch...HealthXn
The document discusses the future of mental health and technology, including:
- Technology may help address challenges in healthcare systems but also presents pitfalls if not implemented carefully.
- The roles of health professionals and patients may change as technology becomes more integrated in care, requiring new skills.
- Data and information from various sources can provide insights if analyzed properly, but also raise privacy and security concerns.
- Future health systems will rely more on knowledge management and using data/analytics to provide personalized, predictive care while maintaining the human touch.
May 2021 snapshot of some of the Research and Collaborations in dHealth/personalized health, public health, epidemiology, biomedicine at the AI Institute of the University of South Carolina [AIISC]
The Future of mHealth - Jay Srini - March 2011LifeWIRE Corp
Jay Srini's presentation of her take on the Future of mHealth, presented at the 3rd mHealth Networking Conference, March 30, 2011. Aside from being one of the preeminent thought leader in the area of innovation and mhealth, she holds a number of positions including Assistant Professor at the University of Pittsburgh and CIO for LifeWIRE Corp.
This document discusses the promise and challenges of data analytics in healthcare and biomedical research. It notes that we are at a point of deception, where digitization is disrupting traditional models through increased data volume, velocity and variety. The document outlines NIH's Big Data to Knowledge initiative to accelerate biomedical discovery through open data sharing and improved analytics. Precision medicine is highlighted as one area that could see major breakthroughs through these approaches. Challenges around data standards, privacy, workforce needs and demonstrating value are also discussed.
This document summarizes the transition from clinical information systems to health grids and the future of health research infrastructure. It discusses trends like rising populations in Asia, increasing resource scarcity, and the need for multidisciplinary and open collaboration. Health grids are presented as enabling virtual collaborations across institutions. Key areas like medical imaging, computational models, and genomic medicine are highlighted. Adoption challenges and requirements like reliable, usable infrastructure are also summarized.
Studying and Using Social Media in Academic Research_Paton_Chrisyan_stanford
The document discusses using social media in academic research. It provides examples of studies using technologies like iPods, Twitter, Facebook and Skype for data collection and communication. It raises questions about developing research methods for studying social media given its rapid evolution. It also discusses establishing a research agenda for IMIA to explore leveraging social tools and implications at the intersection of health, informatics and social media.
Meeting healthcare challenges: what are the challenges and what is the role o...Mohammad Al-Ubaydli
The document discusses the challenges facing healthcare systems and the role that e-health can play in addressing these challenges. The major challenges are quality and safety, access, responsiveness, and affordability. E-health can help by providing access to electronic patient records, reducing complexity, optimizing information processing, and increasing efficiency. It can also help with navigation through the healthcare system and engaging patients in their own health. The document advocates for free access to research information and using data to identify at-risk patients in need of care.
Mobile health is an ever expanding field, and shows great promise for delivering care to remote patients. In this presentation at the ATA 2012 conference, Dr. Robert Ciulla demonstrates the potential for mHealth to improve care availability and how T2 is supporting that goal.
Professor Jeremy Wyatt- Health Futures: Real or Virtual? Warwick Knowledge
This document discusses the potential for virtual healthcare to address current and future challenges facing the UK healthcare system. It outlines problems with the current NHS model and explores how digital technologies could enable new forms of virtual healthcare delivery. While virtual healthcare may increase access and lower costs, the document notes important ethical, implementation, and public acceptance issues that would need to be addressed for it to become a widespread replacement for traditional healthcare delivery.
This is a brief a brief review of current multi-disciplinary and collaborative projects at Kno.e.sis led by Prof. Amit Sheth. They cover research in big social data, IoT, semantic web, semantic sensor web, health informatics, personalized digital health, social data for social good, smart city, crisis informatics, digital data for material genome initiative, etc. Dec 2015 edition.
Strengthening Health Systems through the application of Wireless TechnologyOPS Colombia
Presentación realizada por el Dr. Trishan Panch, de Harvard School of Public Health, el 20 de Septiembre en OPS Colombia, en el espacio de intercambio sobre e-health.
El Dr. Panch, participa, con el auspicio de esta Representación, como conferencista en el IV Congreso Colombiano de Bioingeniería e Ingeniería Biomédica que se realizará en Barranquilla del 21 al 24 de septiembre del 2011.
Web 2.0 systems supporting childhood chronic disease management: a general ar...Gunther Eysenbach
The document proposes a general architecture for Web 2.0 systems that support chronic disease management in children. The architecture is designed to be compliant with the World Health Assembly eHealth resolution. It involves three main services: access to resources for developing competencies in disease management, endorsement of peer-to-peer learning about disease management, and accreditation of learning materials and processes. Design patterns are used to represent core elements like access rights, regulatory frameworks, and values like individual customization and community belonging. The architecture allows an "ecological" development of user-generated content while ensuring medical quality and respecting constraints from the eHealth resolution.
This document discusses the use of social technologies (Web 2.0) in healthcare contexts. It outlines how consumers, clinicians, students, and others use tools like wikis, blogs, social networks and video sharing to collaborate on health issues. Examples are given of support communities and knowledge sharing between patients and providers. While social tools provide benefits of access and support, risks around privacy, security and misinformation must be managed. When used responsibly, these technologies can help empower patients and connect healthcare stakeholders.
Big Data in Biomedicine: Where is the NIH HeadedPhilip Bourne
The National Institutes of Health (NIH) is taking actions to address the implications of big data for biomedical research and healthcare. These include developing a "Commons" approach to make data findable, accessible, interoperable and reusable. The NIH is also establishing initiatives like the Precision Medicine Initiative to generate large datasets and the Center for Predictive Computational Phenotyping to develop predictive models from electronic health records. Overall, the NIH aims to train a workforce equipped for data science and facilitate open collaboration to realize the potential of big data for improving health outcomes.
This document discusses geohealth, which combines geospatial data and digital technologies to improve public health. It addresses challenges like personalized healthcare, data-driven societies, and smart environments. Geohealth research focuses on topics like infection prevention, one health, and quantified self. Combining eHealth platforms, geospatial data, and other digital tools can help monitor health risks in real-time, predict disease outbreaks, and develop tailored interventions. The document also discusses collaborations and education initiatives around geohealth.
This document discusses geohealth, which combines geospatial data and digital technologies to improve public health. It addresses challenges like personalized healthcare, data-driven societies, and smart environments. Geohealth research focuses on topics like infection prevention, one health, and quantified self. Combining eHealth platforms, geospatial data, and other digital tools can help monitor health risks in real-time and tailor interventions. Collaboration across different fields and countries is needed to further geohealth research and applications. The goal is to use new technologies and data to more effectively ensure safety, health, and well-being.
This document outlines Gonzalo Bacigalupe's presentation on social technologies and collaborative health. The presentation defines social media tools, categorizes emerging technologies, and discusses their impact on patients, providers and policy. It also evaluates challenges and approaches to using social tools to strengthen collaborative healthcare practices. The document provides objectives, expected outcomes, descriptions of social media and applications, and a methodology for analyzing e-health tools. It introduces criteria to assess tools' collaborative potential and categories like clinical networks, e-patient networks and mobile apps.
Similar to Changing the World in Healthcare, Education, and Energy through Science, Technology, and Social Entrepreneurship & Innovation (20)
Explore the key differences between silicone sponge rubber and foam rubber in this comprehensive presentation. Learn about their unique properties, manufacturing processes, and applications across various industries. Discover how each material performs in terms of temperature resistance, chemical resistance, and cost-effectiveness. Gain insights from real-world case studies and make informed decisions for your projects.
Changing the World in Healthcare, Education, and Energy through Science, Technology, and Social Entrepreneurship & Innovation
1. Changing the World in Healthcare,
Education, and Energy through
Science, Technology, and Social
Entrepreneurship & Innovation
Mohamed Labadi
MONABIPHOT Summer School Contest
June 26th, 2015
2. Top challenges for the future of
humanity and the planet
We live in a world with staggering challenges—education,
energy, environment, food, global health, poverty,
security, space, water—that need to be addressed.
4. 1. Global Scientific Social online
Networking platform
The world needs an a global scientific network or
organization dedicated to addressing the most serious
global health and medicine issues and challenges
6. Health Gate
A global scientific and
collaborative research
Social networking
Website/platform with a mission to connect, inspire and
empower a global community of scientists and physicians to
find and develop sustainable solutions to the most difficult
health and medicine problems facing humanity and to
positively impact billions of lives.
7. 2. Low-cost Breath Analysis
Medical Device
“The more we look into the breath, the more we find.”
“We realize now that anything in your body that is
eventually in the blood, can be measured in your
breath.”
— Dr. Raed Dweik, Professor of Medicine and Director of the Pulmonary Vascular
Program at Cleveland Clinic (Cleveland, OH)
8. Nitric oxide (NO), Carbon monoxide (CO) and volatile
organic compounds (VOCs)
Human breath contains upwards of 300 chemicals
Methods;(1). GC-MS (2) Chemical sensors (3) Laser spectroscopic
techniques
Biomarkers
9. Chronic obstructive pulmonary disease (COPD)
Sleep apnea
Cystic fibrosis (CF)
Asthma
Cancers: Lung, Colon, Breast, etc
Bronchiectasis
Interstitial lung disease
Multiple sclerosis
Parkinson's disease
Tuberculosis
Diabetes
Pentane and Ethane
asthma, COPD, obstructive sleep
apnea, and pneumonia
VOCs, NO, CO, H2O2
asthma, COPD and CF
VOCs from C4 to C10
alkanes and monomethylated alkane clues to
a number of lung cancer
Isoprostanes
Asthma and COPD
Specific Diseases
10. Device connected
to a smartphone
Biomarkers
•There are over 300 compounds in the breath
• Some of which are established indicators of diseases
• To use these indicators we need a Very selective sensor for a
particular gas and chemical compounds
11. Work Mechanism of the device
Electrical signal (Sensor)
Data: biomarkers (nano-
electrode detector)
Transfered to a smartphone (with a
software in the cloud): To be analyzed and
then compared with a database of
deseases biomarkers
13. Signal will be
transferred to the
Smartphone is order to
be Analyzed as a data
In order to perform an analysis, the signal will be transferred to the Smartphone
that has a software in the cloud (application) with a particular detection problem
and a database of the diseases biomarkers (for the comparison)
Device Development
15. Private Tutoring Market
Global: $102.8 Billion
(2018)
South Korea: $13.9 billion
(2012)
USA: $40 Billion (2014)
India: $13 Billion (2014)
“Online” Tutoring in the
US: $5 Billion (2018)
FACTS
About 40% of students
need extra educational
support
Lower income students
can't access to private
tutoring
Inequality between
children of different
socioeconomic
backgrounds worldwide
Problem
FREE Tutoring: a
web platform to
help low income
students worldwide
get free tutoring by
connecting them
with volunteers
tutors
Solution
Private Tutoring - Problems
16. An Online Tutoring Platform
with a simple mission – connect
students of all levels and tutors
(volunteers) and all over the
world to get online and/or out-
line free tutoring and resources
needed to reach their full
potential and goals.
EduHelp.me
18. WeShareEnergy
A global crowdfunding
and crowdinvesting
platform for sustainable
energy and energy
efficiency projects and
startups.
The platform will be for site owners/initiatives & project
developers around the world to successfully raise money to
build and manage commercial scale solar, wind, smart energy,
and energy efficiency projects in their community.
19. Questions?
Thank you for your attention!
“Global health and global education problems & challenges are a single-point
failure for humanity.” — Mohamed Labadi